4591 logo

Ribomic Inc. Stock Price

TSE:4591 Community·JP¥4.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4591 Share Price Performance

JP¥0
-84.00 (-100.00%)
JP¥0
-84.00 (-100.00%)
Price JP¥0

4591 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

Ribomic Inc. Key Details

JP¥0

Revenue

JP¥334.0m

Cost of Revenue

-JP¥334.0m

Gross Profit

JP¥719.0m

Other Expenses

-JP¥1.1b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 12, 2026
-19.39
0%
0%
0%
View Full Analysis

About 4591

Founded
2003
Employees
25
CEO
Yoshikazu Nakamura
WebsiteView website
www.ribomic.com

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. The company was incorporated in 2003 and is headquartered in Tokyo, Japan.

Recent 4591 News & Updates

We're Hopeful That Ribomic (TSE:4591) Will Use Its Cash Wisely

Dec 08
We're Hopeful That Ribomic (TSE:4591) Will Use Its Cash Wisely

Recent updates

No updates